Creo Medical Group PLC (LON:CREO - Get Free Report) insider Christopher Paul Hancock purchased 4,712 shares of the firm's stock in a transaction on Monday, January 20th. The shares were purchased at an average cost of GBX 19 ($0.23) per share, with a total value of £895.28 ($1,103.92).
Creo Medical Group Price Performance
CREO remained flat at GBX 18.50 ($0.23) during trading on Tuesday. 222,732 shares of the company's stock were exchanged, compared to its average volume of 735,321. The stock has a market capitalization of £66.93 million, a PE ratio of -308.33 and a beta of 0.86. Creo Medical Group PLC has a 12 month low of GBX 12 ($0.15) and a 12 month high of GBX 43 ($0.53). The stock has a 50-day moving average of GBX 17.54 and a two-hundred day moving average of GBX 23.61. The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19.
Creo Medical Group Company Profile
(
Get Free Report)
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.
Featured Articles
Before you consider Creo Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Creo Medical Group wasn't on the list.
While Creo Medical Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
